Study

Elucidating Transcription Regulation by Epigenetics in Neuroblastoma

Study ID Alternative Stable ID Type
phs001831 Cohort

Study Description

PURPOSE
Whole-genome profiles of the epigenetic modification 5-hydroxymethylcytosine (5-hmC) are robust diagnostic biomarkers in adult patients with cancer. We investigated if 5-hmC profiles would serve as novel prognostic markers in neuroblastoma, a clinically heterogeneous pediatric cancer. Because this DNA modification facilitates active gene expression, we hypothesized that 5-hmC profiles would identify transcriptomic networks driving the clinical behavior of neuroblastoma.

PATIENTS AND METHODS
Nano-hmC-Seal sequencing was performed on DNA from Discovery (n = 51), Validation (n = 38), and Children's Oncology Group (n = 20) cohorts of neuroblastoma tumors. RNA was isolated from 48 tumors for RNA sequencing. Genes with differential 5-hmC or expression between clusters were identified using DESeq2. A 5-hmC model predicting outcome in high-risk patients was established using linear discriminant analysis.

RESULTS
Comparison of low- versus high-risk tumors in the Discovery cohort revealed 577 genes with ... (Show More)

Archive Link Archive Accession
dbGaP phs001831

Who archives the data?

There are no publications available